GRDN logo

Guardian Pharmacy Services, Inc. Stock Price

NYSE:GRDN Community·US$2.3b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

GRDN Share Price Performance

US$36.61
10.09 (38.05%)
US$34.00
Fair Value
US$36.61
10.09 (38.05%)
7.7% overvalued intrinsic discount
US$34.00
Fair Value
Price US$36.61
AnalystConsensusTarget US$34.00

GRDN Community Narratives

·
Fair Value US$34 7.7% overvalued intrinsic discount

Rising Senior Populations And Industry Consolidation Will Support Long Term Pharmacy Demand

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
US$34
7.7% overvalued intrinsic discount
Revenue
5.83% p.a.
Profit Margin
5.25%
Future PE
30.5x
Price in 2028
US$41.6

Trending Discussion

Updated Narratives

GRDN logo

Rising Senior Populations And Industry Consolidation Will Support Long Term Pharmacy Demand

Fair Value: US$34 7.7% overvalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with acceptable track record.

1 Risk
3 Rewards

Guardian Pharmacy Services, Inc. Key Details

US$1.5b

Revenue

US$1.2b

Cost of Revenue

US$304.7m

Gross Profit

US$251.6m

Other Expenses

US$53.1m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.84
20.93%
3.64%
0%
View Full Analysis

About GRDN

Founded
2003
Employees
3600
CEO
Fred Burke
WebsiteView website
guardianpharmacy.com

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company’s individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Recent GRDN News & Updates

Seeking Alpha Apr 15

Guardian Pharmacy Services: Waiting For A Better Entry Point

Summary Guardian Pharmacy Services (GRDN) earns a hold rating due to robust fundamentals but stretched valuation. GRDN’s moat is rooted in workflow integration and specialized tools, driving high adoption in assisted living and behavioral health facilities. The Inflation Reduction Act poses a revenue headwind, but GRDN’s margin resilience and scale position it to weather and even benefit competitively. At ~30x NTM PE, GRDN trades at a premium to peers and its historical average, limiting near-term upside despite strong execution. Read the full article on Seeking Alpha

Recent updates

No updates